fig2
![The <i>TNNI3</i> p.R186Q mutation is responsible for hypertrophic cardiomyopathy via promoting FASN-stimulated abnormal fatty acid metabolism](https://image.oaes.cc/77c8bd4b-4af1-454c-bb0d-654b20239147/5337.fig.2.jpg)
Figure 2. Tnni3R186Q/R186Q mice exhibit aberrant fatty acid metabolism. (A) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of differentially expressed genes in Tnni3+/+ and Tnni3R186Q/R186Q mice ventricular myocardium (n = 3 per group). (B) Lipogenesis in the ventricular myocardium from Tnni3+/+ and Tnni3R186Q/R186Q mice was determined by Oil Red O staining using frozen sections (n = 3 per group). (C-E) The levels of TG, TC and LDL were individually measured using enzyme-linked immunosorbent assay in the ventricular myocardium of Tnni3+/+ and Tnni3R186Q/R186Q mice (n = 3 per group). (F-H) The levels of TG, TC and LDL were individually measured using enzyme-linked immunosorbent assay in the serum of fasting Tnni3+/+ and Tnni3R186Q/R186Q mice (n = 3 per group).